Rep. Earl L. "Buddy" Carter (R-GA) today led 11 bipartisan members of Congress in introducing the PBM Reform Act, which protects patients and pharmacies from the harmful and anticompetitive business practices of pharmacy benefit managers (PBM).
"It's time to bust up the PBM monopoly, which has been stealing hope and health from patients for decades. As a pharmacist, I've seen how PBMs abuse patients firsthand, and believe that the cure to this infectious disease is transparency, competition, and accountability, which is exactly what our bipartisan package provides,"— Rep. Carter
The legislation will ban "spread pricing" in Medicaid and move to a transparent system that ensures pharmacies are fairly and adequately reimbursed for their services.
This bipartisan effort represents a significant step toward addressing the complex web of pharmacy benefit manager practices that have contributed to rising prescription drug costs for American patients. The reform package aims to increase transparency and competition in the pharmaceutical supply chain.
For consumers using tools like RxPriceGuide to compare prescription prices, these reforms could lead to more competitive pricing and better access to affordable medications across different pharmacy networks.
Source: Press release from the office of Rep. Buddy Carter, July 10, 2025. This article provides analysis and context for RxPriceGuide readers interested in prescription drug policy developments.
Learn how pharmacy benefit managers use spread pricing and its impact on drug costs.
Tips and tools for comparing prescription drug prices across different pharmacies.